← FDA Drug Approvals (Drugs@FDA)

LAMOTRIGINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ALEMBIC · Approved 2024-10-01

Drug application

FDA Application #

ANDA211821

Application type

Abbreviated New Drug Application (Generic)

Brand name

LAMOTRIGINE

Generic name

LAMOTRIGINE

Active ingredients

LAMOTRIGINE

Dosage form

TABLET, EXTENDED RELEASE

Route

ORAL

Marketing status

Prescription

Sponsor

ALEMBIC

Manufacturer

Alembic Pharmaceuticals Limited

First approval

2024-10-01

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown